Description: Revelation Biosciences, Inc. - Unit, a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses or entities.
Home Page: www.revbiosciences.com
REVBU Technical Analysis
4660 La Jolla Village Drive
San Diego,
CA
92122
United States
Phone:
650-800-3717
Officers
| Name | Title |
|---|---|
| Mr. James M. Rolke | CEO & Director |
| Mr. Chester Stanley Zygmont III | Chief Financial Officer |
| Ms. Sandra Vedrick | VP of HR & Investor Relations |
| Ms. Carol Odle | Sr. Director of Clinical Projects |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2020-10-08 |
| Fiscal Year End: | December |
| Full Time Employees: | 14 |